ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $55,000 | -30.4% | 30,000 | 0.0% | 0.01% | -31.6% |
Q2 2021 | $79,000 | -37.3% | 30,000 | -14.3% | 0.02% | -42.4% |
Q1 2021 | $126,000 | -43.5% | 35,000 | -60.5% | 0.03% | -52.9% |
Q4 2020 | $223,000 | -69.4% | 88,525 | -69.4% | 0.07% | -73.6% |
Q3 2020 | $728,000 | -4.1% | 289,025 | +24.6% | 0.26% | -7.0% |
Q2 2020 | $759,000 | +34.3% | 232,025 | +0.7% | 0.28% | +9.6% |
Q1 2020 | $565,000 | -75.4% | 230,525 | -52.6% | 0.26% | -39.4% |
Q4 2019 | $2,294,000 | +122.5% | 486,050 | +101.8% | 0.43% | -7.3% |
Q3 2019 | $1,031,000 | -18.5% | 240,800 | +11.0% | 0.46% | -19.9% |
Q2 2019 | $1,265,000 | +64.3% | 216,950 | +8.5% | 0.58% | +55.8% |
Q1 2019 | $770,000 | +118.1% | 199,950 | +5.8% | 0.37% | +71.0% |
Q4 2018 | $353,000 | – | 188,950 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 15,151,516 | $38,182,000 | 7.99% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 10,406,850 | $26,225,000 | 4.02% |
MILLER VALUE PARTNERS, LLC | 12,385,586 | $31,211,000 | 1.12% |
CHIRON CAPITAL MANAGEMENT, LLC | 201,470 | $508,000 | 0.41% |
Sargent Investment Group, LLC | 289,025 | $728,000 | 0.26% |
MAGNOLIA CAPITAL ADVISORS LLC | 80,542 | $404,000 | 0.16% |
XTX MARKETS LLC | 11,086 | $28,000 | 0.14% |
Virtus ETF Advisers LLC | 99,108 | $250,000 | 0.13% |
Old West Investment Management, LLC | 210,226 | $529,000 | 0.12% |
EQUITEC PROPRIETARY MARKETS, LLC | 31,300 | $79,000 | 0.06% |